Search

everythinglearnresearchcommunity

for

Search:↓

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.

Neuronatin is found in specific cells within rat testis, hair follicles, tongue, and pancreas, suggesting it has various roles in tissue development and function.

CA VI helps maintain pH balance and is important for various bodily functions.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Bioengineered salivary glands in mice can produce saliva when tasting sour or bitter, but have different protein levels and nerve signals compared to natural glands.

Activating TRPV3 stops human hair growth.

Touch sensitivity in mouse skin decreases during hair growth due to changes in touch receptors.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Lowering testosterone speeds up wound healing in male mice.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.